Literature DB >> 21296599

How valuable are multiple treatment comparison methods in evidence-based health-care evaluation?

Nicola J Cooper1, Jaime Peters, Monica C W Lai, Peter Juni, Simon Wandel, Steve Palmer, Mike Paulden, Stefano Conti, Nicky J Welton, Keith R Abrams, Sylwia Bujkiewicz, David Spiegelhalter, Alex J Sutton.   

Abstract

OBJECTIVES: To compare the use of pair-wise meta-analysis methods to multiple treatment comparison (MTC) methods for evidence-based health-care evaluation to estimate the effectiveness and cost-effectiveness of alternative health-care interventions based on the available evidence.
METHODS: Pair-wise meta-analysis and more complex evidence syntheses, incorporating an MTC component, are applied to three examples: 1) clinical effectiveness of interventions for preventing strokes in people with atrial fibrillation; 2) clinical and cost-effectiveness of using drug-eluting stents in percutaneous coronary intervention in patients with coronary artery disease; and 3) clinical and cost-effectiveness of using neuraminidase inhibitors in the treatment of influenza. We compare the two synthesis approaches with respect to the assumptions made, empirical estimates produced, and conclusions drawn.
RESULTS: The difference between point estimates of effectiveness produced by the pair-wise and MTC approaches was generally unpredictable-sometimes agreeing closely whereas in other instances differing considerably. In all three examples, the MTC approach allowed the inclusion of randomized controlled trial evidence ignored in the pair-wise meta-analysis approach. This generally increased the precision of the effectiveness estimates from the MTC model.
CONCLUSIONS: The MTC approach to synthesis allows the evidence base on clinical effectiveness to be treated as a coherent whole, include more data, and sometimes relax the assumptions made in the pair-wise approaches. However, MTC models are necessarily more complex than those developed for pair-wise meta-analysis and thus could be seen as less transparent. Therefore, it is important that model details and the assumptions made are carefully reported alongside the results.
Copyright © 2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21296599     DOI: 10.1016/j.jval.2010.09.001

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  20 in total

1.  Output correlations in probabilistic models with multiple alternatives.

Authors:  Klemen Naveršnik
Journal:  Eur J Health Econ       Date:  2014-01-04

2.  Network vs. pairwise meta-analyses: a case study of the impact of an evidence-synthesis paradigm on value of information outcomes.

Authors:  Zafar Zafari; Kristian Thorlund; J Mark FitzGerald; Carlo A Marra; Mohsen Sadatsafavi
Journal:  Pharmacoeconomics       Date:  2014-10       Impact factor: 4.981

3.  A Bayesian approach to discrete multiple outcome network meta-analysis.

Authors:  Rebecca Graziani; Sergio Venturini
Journal:  PLoS One       Date:  2020-04-28       Impact factor: 3.240

4.  Digital interventions in mental health: evidence syntheses and economic modelling.

Authors:  Lina Gega; Dina Jankovic; Pedro Saramago; David Marshall; Sarah Dawson; Sally Brabyn; Georgios F Nikolaidis; Hollie Melton; Rachel Churchill; Laura Bojke
Journal:  Health Technol Assess       Date:  2022-01       Impact factor: 4.014

5.  The effectiveness of different interventions to promote poison prevention behaviours in households with children: a network meta-analysis.

Authors:  Felix A Achana; Alex J Sutton; Denise Kendrick; Persephone Wynn; Ben Young; David R Jones; Stephanie J Hubbard; Nicola J Cooper
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

6.  Evidence synthesis for decision making 7: a reviewer's checklist.

Authors:  A E Ades; Deborah M Caldwell; Stefanie Reken; Nicky J Welton; Alex J Sutton; Sofia Dias
Journal:  Med Decis Making       Date:  2013-07       Impact factor: 2.583

7.  Use of mixed-treatment-comparison methods in estimating efficacy of treatments for heavy menstrual bleeding.

Authors:  David C Hoaglin; Anna Filonenko; Mark E Glickman; Radek Wasiak; Risha Gidwani
Journal:  Eur J Med Res       Date:  2013-06-21       Impact factor: 2.175

8.  Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis.

Authors:  C Cooper; R Lester; K Thorlund; E Druyts; A C El Khoury; S Yaya; E J Mills
Journal:  QJM       Date:  2012-11-17

9.  No role for initial severity on the efficacy of antidepressants: results of a multi-meta-analysis.

Authors:  Konstantinos N Fountoulakis; Areti Angeliki Veroniki; Melina Siamouli; Hans-Jürgen Möller
Journal:  Ann Gen Psychiatry       Date:  2013-08-13       Impact factor: 3.455

10.  Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis.

Authors:  Eliano P Navarese; Kenneth Tandjung; Bimmer Claessen; Felicita Andreotti; Mariusz Kowalewski; David E Kandzari; Dean J Kereiakes; Ron Waksman; Laura Mauri; Ian T Meredith; Aloke V Finn; Hyo-Soo Kim; Jacek Kubica; Harry Suryapranata; Toni Mustahsani Aprami; Giuseppe Di Pasquale; Clemens von Birgelen; Elvin Kedhi
Journal:  BMJ       Date:  2013-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.